After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
We are very excited to launch our new website! Please take a few moments to click around and explore...